6-MERCAPTOPURINE - CYTOTOXICITY AND BIOCHEMICAL PHARMACOLOGY IN HUMAN-MALIGNANT T-LYMPHOBLASTS

被引:83
作者
BOKKERINK, JPM
STET, EH
DEABREU, RA
DAMEN, FJM
HULSCHER, TW
BAKKER, MAH
VANBAAL, JA
机构
[1] Center for Pediatric Oncology S.E. Netherlands, Department of Pediatrics, St. Radboud University Hospital of Nijmegen
关键词
D O I
10.1016/0006-2952(93)90045-X
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The effects of prolonged exposure to 2 and 10 muM 6-mercaptopurine (6MP) in the human lymphoblastic T-cell line MOLT-4 were studied with respect to cell-kinetic parameters, phosphoribosyl pyrophosphate (PRPP) and purine ribonucleotide levels, formation of 6MP-nucleotides, especially methyl-thio-IMP (Me-tIMP), DNA and RNA synthesis ([P-32] incorporation), and [8-C-14]6MP incorporation into newly synthesized DNA and RNA. The results provided new insights into the complex mechanism of action of 6MP in human malignant lymphoblasts. Exposure to 2 muM 6MP resulted in a rapid inhibition of purine de novo synthesis (PDNS) by increased levels of Me-tIMP, resulting in increased PRPP levels and decreased purine ribonucleotides, affecting cell growth and clonal growth, and less cell death. DNA synthesis decreased, associated with an increasing delay of cells in S phase. Incorporation of thioguanine nucleotides into newly synthesized DNA resulted in an increasing arrest of cells in G2 + M phase. RNA synthesis, initially decreased, recovered partially, associated with a recovery of purine ribonucleotides. New formation of 6MP-nucleotides (tIMP) was only detected within the first 24 hr, and 6MP levels in the culture medium were already undetectable after 6 hr of exposure to 2 muM, indicating a high rate of incorporation and complete conversion of 6MP within this period. Incorporation of 6MP-nucleotides into DNA was 5 times as high as incorporation into RNA. Exposure to 10 muM 6MP resulted in early cytotoxicity at 24 hr, associated with a complete inhibition of PDNS by a large pool of Me-tIMP and lower levels of purine ribonucleotides as compared to 2 muM 6MP. A more severe delay of cells in S phase was associated with an inhibition of DNA synthesis to 14% of control within the first 24 hr, and an arrest in G2 + M phase. Further increasing levels of Me-tIMP caused an arrest of cells and late cytotoxicity in S phase at 48 hr, preventing further progression into G2 + M Phase. Our data suggest that inhibition of PDNS due to Me-tIMP is a crucial event in the mechanism of 6MP cytotoxicity. It is responsible for decreased RNA synthesis and decreased availability of natural deoxyribonucleotides, causing a delay of DNA synthesis in S phase. This enhances incorporation of 6MP as thioguanine nucleotides into DNA in the S phase and subsequent late cytotoxicity in the G2 phase. However, with high concentrations of 6MP, the large pool of Me-tIMP causes severe reduction of natural deoxyribonucleotides in lymphoblasts with an active PDNS. This is responsible for pronounced inhibition of DNA synthesis and early cytotoxicity in the S phase.
引用
收藏
页码:1455 / 1463
页数:9
相关论文
共 47 条
[1]
A PHASE-II TRIAL OF CONTINUOUS-INFUSION 6-MERCAPTOPURINE FOR CHILDHOOD SOLID TUMORS [J].
ADAMSON, PC ;
ZIMM, S ;
RAGAB, AH ;
STEINBERG, SM ;
BALIS, F ;
KAMEN, BA ;
VIETTI, TJ ;
GILLESPIE, A ;
POPLACK, DG .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (05) :343-344
[2]
BARRANCO SC, 1971, CANCER RES, V31, P583
[3]
BENNETT LL, 1971, CANCER RES, V31, P152
[4]
ACTIVITY AND MECHANISM OF ACTION OF 6-METHYLTHIOPURINE RIBONUCLEOSIDE IN CANCER CELLS RESISTANT TO 6-MERCAPTOPURINE [J].
BENNETT, LL ;
BROCKMAN, RW ;
SCHNEBLI, HP ;
CHUMLEY, S ;
DIXON, GJ ;
SCHABEL, FM ;
DULMADGE, EA ;
SKIPPER, HE ;
MONTGOMERY, JA ;
THOMAS, HJ .
NATURE, 1965, 205 (4978) :1276-+
[5]
BODEY GP, 1968, CANCER CHEMOTH REP, V52, P315
[6]
SEQUENCE-DEPENDENT, TIME-DEPENDENT AND DOSE-DEPENDENT SYNERGISM OF METHOTREXATE AND 6-MERCAPTOPURINE IN MALIGNANT HUMAN T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
BAKKER, MAH ;
HULSCHER, TW ;
DEABREU, RRA ;
SCHRETLEN, EDAM ;
VANLAARHOVEN, JPRM ;
DEBRUYN, CHMM .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (20) :3549-3555
[7]
EFFECTS OF METHOTREXATE ON PURINE AND PYRIMIDINE METABOLISM AND CELL-KINETIC PARAMETERS IN HUMAN-MALIGNANT LYMPHOBLASTS OF DIFFERENT LINEAGES [J].
BOKKERINK, JPM ;
DEABREU, RA ;
BAKKER, MAH ;
HULSCHER, TW ;
VANBAAL, JM ;
SCHRETLEN, EDAM ;
DEBRUIJN, CHMM .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (12) :2329-2338
[8]
PURINE DENOVO SYNTHESIS AS THE BASIS OF SYNERGISM OF METHOTREXATE AND 6-MERCAPTOPURINE IN HUMAN-MALIGNANT LYMPHOBLASTS OF DIFFERENT LINEAGES [J].
BOKKERINK, JPM ;
BAKKER, MAH ;
HULSCHER, TW ;
DEABREU, RA ;
SCHRETLEN, EDAM .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (12) :2321-2327
[9]
DOSE-RELATED EFFECTS OF METHOTREXATE ON PURINE AND PYRIMIDINE NUCLEOTIDES AND ON CELL-KINETIC PARAMETERS IN MOLT-4 MALIGNANT HUMAN T-LYMPHOBLASTS [J].
BOKKERINK, JPM ;
DEABREU, RA ;
BAKKER, MAH ;
HULSCHER, TW ;
VANBAAL, JM ;
DEVAAN, GAM .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (20) :3557-3564
[10]
BRUCE WR, 1969, JNCI-J NATL CANCER I, V42, P1015